Larval diet and temperature alter mosquito immunity and development: using body size and developmental traits to track carry-over effects on longevity | Parasites
Health Reporter,
Inactivation of human coronaviruses using an automated room disinfection device
Health Reporter,
Inflammatory cell dying, PANoptosis, display screen identifies host elements in coronavirus innate immune response as therapeutic targets – Communications Biology
PressNewsAgency,
Dong, E., Du, H.
Could fused neurons explain COVID-19’s ‘brain fog’?
Science Magazine,
Of all of COVID-19’s symptoms, one of the most troubling is “brain fog.” Victims report headache, trouble concentrating, and…
Reliance submits proposal for potential Covid-19 drug
The Deccan Herald,
Reliance Industries Ltd's R
Reliance submits proposal for potential Covid drug - ET HealthWorld
Times of India,
New Delhi: Reliance Industries Ltd's R
Reliance proposes using tapeworm drug to treat Covid
rediff.com,
Reliance Industries Ltd's R
Reliance submits proposal for potential Covid drug
Times of India,
NEW DELHI: Reliance Industries Ltd 's R
Reliance submits proposal for potential Covid drug
Times of India,
NEW DELHI: Reliance Industries Ltd 's R
Reliance submits proposal for potential COVID drug India
Devdiscourse,
Reliance Industries Ltd's R
Reliance submits proposal for potential COVID-19 drug; to develop diagnostic kits and low-cost sanitisers
Yourstory,
Reliance Industries' R
SARS-CoV-2 스파이크-유도 융합체(Syncytia)를 차단하는 TEME16 단백질을 억제하는 약물(Nature)
Nature Asia ,
리서치 하이라이트 2021년6월3일 Nature 594, 7861 Mauro Giacca와 연구진들은 COVID-19로 사망한 대부분의 환자 폐에서 융합 세포(Fused cell) 또는 융합체(Syncytia)의 특성을 가지는 비전…
Reliance Submits Proposal To Use Tapeworm Infestation Drug Niclosamide For COVID-19 Treatment
Moneycontrol.com,
Reliance has also developed the Nexar Polymer liquid and the R-Green COVID-19 detection kits, among other items that will help…
AzurRx BioPharma CEO Issues Letter to Shareholders - Apr 15, 2021
Biospace,
DELRAY BEACH, Fla., April 15, 2021 (GLOBE NEWSWIRE) -- AzurRx BioPharma, Inc. (NASDAQ: ), (“AzurRx” or the “Company”), a…
AzurRx BioPharma CEO Issues Letter to Shareholders
Spoke,
DELRAY BEACH, Fla., April 15, 2021 (GLOBE NEWSWIRE) -- AzurRx BioPharma, Inc. (NASDAQ: AZRX ), (“AzurRx” or the “Company”), a…
AzurRx BioPharma CEO Issues Letter to Shareholders
MarketScreener,
DELRAY BEACH, Fla., April 15, 2021 (GLOBE NEWSWIRE) -- AzurRx BioPharma, Inc. (NASDAQ: ), (“AzurRx” or the “Company”), a…
AzurRx BioPharma CEO Issues Letter to Shareholders
Morning Star,
DELRAY BEACH, Fla., April 15, 2021 (GLOBE NEWSWIRE) -- AzurRx BioPharma, Inc. (NASDAQ: AZRX ), (“AzurRx” or the “Company”), a…
Anti-parasitic drug may protect against lung cell fusion induced by SARS-CoV-2
Medical Brief,
A drug that is commonly used to treat tapeworm infections might help to prevent the formation of atypical fused cells in the…
Virology: Anti-parasitic drug may protect against lung cell fusion induced by SARS-CoV-2
Nature Asia ,
Research highlight Nature April 7, 2021 A drug that is commonly used to treat tapeworm infections might help to prevent the…
Covid Booster: herd immunity and nature nurture
COSMOS magazine,
5 things we learned about COVID this week. A review led by Australian researchers has found that no country has had high enough…
Anti-parasitic drug may protect against lung cell fusion induced by SARS-CoV-2 .
infosurhoy,
A drug that is commonly used to treat tapeworm infections might help to prevent the formation of atypical fused cells in the…
Anti-parasitic drug may protect against lung cell fusion induced by SARS-CoV-2
MedicalXpress,
Credit: CC0 A drug that is commonly used to treat tapeworm infections might help to prevent the formation of atypical fused…
Covid, il farmaco Niclosamide potrebbe bloccare il danno polmonare: lo studio
Sky Italia tg24,
È quanto emerso da uno studio del King’s College London, Università di Trieste e Centro di Ingegneria Genetica e Biotecnologie (I…
Coronavirus: un farmaco antiparassitario può proteggere i polmoni
UrbanPost,
Si chiama niclosamide il farmaco che potrebbe essere in grado di bloccare gli effetti dannosi causati ai polmoni dal Sars-CoV-2.
Study shows how tapeworm infestation drug Niclosamide can help treat Covid
The Print,
In India, Modi govt has already given a go-ahead to conduct Phase 2 clinical trials of Niclosamide for treatment of Covid.
Covid, lo scienziato Mauro Giacca: "Così la spike danneggia i polmoni. Con un farmaco proviamo a neutralizzarla"
La Repubblica,
Ancora una volta, la spike. lei, la punta della corona del coronavirus, responsabile dell'ennesima malefatta di Sars-Cov2.
COVID-19: Antiparasitic drug commonly used to treat TAPEWORM infections 'could prevent lung damage'
The Amed Post,
Lung damage in patients with COVID-19 might be preventable using an antiparasitic drug that is commonly employed to treat…
Antiparasitic drug could prevent Covid-19 lung damage
Mirage News,
King’s College London A common antiparasitic drug could block lung damage in people with coronavirus, new research published…
COVID-19: Antiparasitic drug commonly used to treat TAPEWORM infections 'could prevent lung damage' - NewsyPeople
NewsyPeople,
Lung damage in patients with COVID-19 might be preventable using anantiparasitic drug that is commonly employed to treat…
《自然》刊发新冠新研究:一种抗寄生虫药或能预防肺细胞融合
The Paper,
新冠疫情发展至今,除疫苗之外,全球的一些科学团队仍在致力于寻找抗病毒药物,老药新用是筛选候选药物的思路之一。 当地时间4月7日晚间,国际顶级学术期刊《自然》(Nature)以“加快评审文章”(Accelerated Article Preview)形式在线发…
News story from Daily Mail on Wednesday 07 April 2021
Daily Mail,
《自然》刊发新冠新研究:一种抗寄生虫药或能预防肺细胞融合
sina.com.cn,
原标题: 新冠疫情发展至今,除疫苗之外,全球的一些科学团队仍在致力于寻找抗病毒药物,老药新用是筛选候选药物的思路之一。当地时间4月7日晚间,国际顶级学术期刊《自然》(Nature)以“加快评审文章”(Accelerated Article Preview)形…
Drugs that inhibit TMEM16 proteins block SARS-CoV-2 Spike-induced syncytia - Docwire News
Doc Wire News,
This article was originally published here Nature. 2021 Apr 7. doi: 10.1038/s41586-021-03491-6.
Antiparasitic drug could prevent Covid-19 lung damage
bhf.org,
A common antiparasitic drug could block lung damage in people with coronavirus, according to new research part-funded by us and…